0.0700
-0.0046
(-6.17%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-16,934.2280
-15,882.8080
-10,432.7720
-6,811.0790
Investing Cash Flow
-200.2980
-152.6520
-814.7360
-384.1740
Financing Cash Flow
25,188.3620
4,898.9910
26,542.5810
7,974.4550
End Cash Position
10,040.1490
5,356.2760
16,492.7450
1,197.6720
Interest Paid Supplemental Data
15.3150
19.0000
114.7250
50.2290
Capital Expenditure
-200.2980
-153.4200
-814.7360
-402.0960
Issuance of Capital Stock
25,205.1530
--
20,374.2180
--
Issuance of Debt
--
5,000.0000
--
954.0000
Repayment of Debt
-16.7910
-15.0900
-936.5940
-485.9170
Free Cash Flow
-17,134.5260
-16,036.2280
-11,247.5080
-7,213.1750
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRES Institute of Biomedical Research Corp.
0.0230
+74.24%
DWTX Dogwood Therapeutics, Inc.
2.3600
-3.67%
TVGNW Tevogen Bio Holdings Inc.
0.0750
-5.66%
KPRX Kiora Pharmaceuticals, Inc.
3.5235
-4.77%
GOVXW GeoVax Labs, Inc.
0.1502
-6.13%
TYRA Tyra Biosciences, Inc.
15.20
-4.82%
PBLA Panbela Therapeutics, Inc.
0.3700
+2.49%
PCSA Processa Pharmaceuticals, Inc.
0.8512
-1.49%
ACRV Acrivon Therapeutics, Inc.
5.47
-10.33%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%